Patient Data Analytics Market Size

Patient Data Analytics Market size was over USD 40.01 billion in 2024 and is anticipated to cross USD 263.4 billion by 2037, witnessing more than 15.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of patient data analytics is assessed at USD 45 billion.

The growth of the market can be attributed to rising usage of digital healthcare facilities, tele-health apps, and others. There are almost 4 million Americans who use the over 350,00 mobile health apps that are available in app stores. Furthermore, the United Nations along with the World Health Organization, launched a General Program of Work, 2019-2023, to achieve the development goals of healthcare, that includes, increasing the development, scaling and adoption of digital health solutions.

In addition to these, factors that are believed to fuel the market growth of patient data analytics include the increasingly focusing on cost-cutting and adopting procedures that guarantee the sustainability of operations. This is anticipated to create a rapid demand for patient data analytics as it can help hospitals lower administrative costs, provide improved coordination of treatment, and minimize erroneous and fraudulent payments. Furthermore, improvements in healthcare infrastructure in emerging economies and rising awareness about advantages of patient data analytics are also assessed to fuel market growth. According to the report of US National library of Medicine, as of June 2021, United States alone accounted for the submission of 35% of the total clinical studies of the organization, which were offered for the purpose of patient data analytics. In addition, increasing collaborations among medical companies and rising number of ongoing clinical studies across the world are further expected to boost the market growth in the upcoming years. Moreover, coronavirus pandemic is predicted to positively affect the market growth as a result of growing number of patient studies related to COVID-19.